Menopause laboratory findings

Jump to navigation Jump to search

Menopause Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasonography

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Menopause laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Menopause laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Menopause laboratory findings

CDC on Menopause laboratory findings

Menopause laboratory findings in the news

Blogs on Menopause laboratory findings

Directions to Hospitals Treating Menopause

Risk calculators and risk factors for Menopause laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Rahmah Al-Edresi, M.D.[2]

Overview

  • An elevated serum of Follicle Stimulating Hormone (FSH) greater than 40 mIU/mL is diagnostic of menopause.[1]
  • A decreased serum of the Anti-Mullerian Hormone level(AMH) is a diagnostic test of premature menopause and a low level of AMH is normal in the postmenopause period.[2]
  • A decreased of Estrogen Hormone level in women with menopause.

References


Template:WikiDoc Sources